We are pleased to announce the expansion of Par Equity to the United States with the opening of our San Francisco based business — Par Equity USA, LLC.
The Fund will invest in medical grade digital technologies with clinical validation in target patient groups. The aim is to provide improved outcomes and lower cost care pathways in the treatment of chronic disorders and build HealthTech businesses that have high value assets.
Par Equity has established a core Investment Team with healthcare and digital technology investment experience in both the US and UK, an Advisory Panel, comprising leading subject matter experts, and an Expert Group to provide specialised input.
